Compile Data Set for Download or QSAR
Report error Found 428 Enz. Inhib. hit(s) with all data for entry = 11603
LigandPNGBDBM631495(US20230348424, Example 78)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631686(US20230348424, Example 269)
Affinity DataIC50: 1.21nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631683(US20230348424, Example 266 | 1-((S)-1-acetyl-3-met...)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631687(US20230348424, Example 270)
Affinity DataIC50: 1.74nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631464(N-((R)-1-(3-(difluoromethyl)-2-fluorophenyl)ethyl)...)
Affinity DataKd:  2nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631496(US20230348424, Example 79 | : N-((R)-1-(3-(difluor...)
Affinity DataKd:  2nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631526(US20230348424, Example 109 | US20230348424, Exampl...)
Affinity DataKd:  2nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631490(US20230348424, Example 73 | 1-((1R,2S)-[1,1′...)
Affinity DataKd:  2nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631543(US20230348424, Example 126 | US20230348424, Exampl...)
Affinity DataKd:  2nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631681(US20230348424, Example 264)
Affinity DataIC50: 2.20nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631684(US20230348424, Example 267)
Affinity DataIC50: 2.44nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631543(US20230348424, Example 126 | US20230348424, Exampl...)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631559(US20230348424, Example 142 | US20230348424, Exampl...)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631545(US20230348424, Example 128 | N-((R)-1-(3- (difluor...)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631561(US20230348424, Example 144 | US20230348424, Exampl...)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631466(US20230348424, Example 49 | US20230348424, Example...)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631524(US20230348424, Example 107 | N-((R)-1-(3- (difluor...)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631573(US20230348424, Example 156)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631489(US20230348424, Example 72 | 1-((1S,2R)-[1,1′...)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631543(US20230348424, Example 126 | US20230348424, Exampl...)
Affinity DataIC50: 3nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631520(US20230348424, Example 103 | US20230348424, Exampl...)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631553(US20230348424, Example 136 | US20230348424, Exampl...)
Affinity DataKd:  3nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631615(US20230348424, Example 198)
Affinity DataIC50: 3.41nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631526(US20230348424, Example 109 | US20230348424, Exampl...)
Affinity DataIC50: 3.60nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631621(US20230348424, Example 204)
Affinity DataIC50: 3.61nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631496(US20230348424, Example 79 | : N-((R)-1-(3-(difluor...)
Affinity DataIC50: 3.70nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631559(US20230348424, Example 142 | US20230348424, Exampl...)
Affinity DataIC50: 3.80nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631561(US20230348424, Example 144 | US20230348424, Exampl...)
Affinity DataIC50: 4nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631487(US20230348424, Example 70 | N-((R)-1-(3-(difluorom...)
Affinity DataKd:  4nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631559(US20230348424, Example 142 | US20230348424, Exampl...)
Affinity DataKd:  4nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631568(US20230348424, Example 151 | US20230348424, Exampl...)
Affinity DataKd:  4nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631627(US20230348424, Example 210)
Affinity DataIC50: 4.30nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631543(US20230348424, Example 126 | US20230348424, Exampl...)
Affinity DataIC50: 4.40nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631464(N-((R)-1-(3-(difluoromethyl)-2-fluorophenyl)ethyl)...)
Affinity DataIC50: 4.5nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631490(US20230348424, Example 73 | 1-((1R,2S)-[1,1′...)
Affinity DataIC50: 4.60nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631620(US20230348424, Example 203)
Affinity DataIC50: 4.60nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631702(US20230348424, Example 285)
Affinity DataIC50: 4.70nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631649(US20230348424, Example 232 | US20230348424, Exampl...)
Affinity DataIC50: 4.80nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631724(US20230348424, Example 307 | N-((R)-1-(3-(difluoro...)
Affinity DataIC50: 4.90nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631559(US20230348424, Example 142 | US20230348424, Exampl...)
Affinity DataIC50: 4.90nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631551(US20230348424, Example 134 | US20230348424, Exampl...)
Affinity DataKd:  5nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631563(US20230348424, Example 146 | US20230348424, Exampl...)
Affinity DataIC50: 5.40nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631612(US20230348424, Example 195)
Affinity DataIC50: 5.44nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

LigandPNGBDBM631520(US20230348424, Example 103 | US20230348424, Exampl...)
Affinity DataIC50: 5.70nMAssay Description:Inhibition of the SOS 1:KRAS interaction was measured using purified GST-tagged KRAS (res. 1-169, G12C, purified based on Hillig, et al., Proc Natl A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631532(US20230348424, Example 115 | US20230348424, Exampl...)
Affinity DataKd:  6nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631469(US20230348424, Example 52)
Affinity DataKd:  6nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631561(US20230348424, Example 144 | US20230348424, Exampl...)
Affinity DataKd:  6nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631534(US20230348424, Example 117 | US20230348424, Exampl...)
Affinity DataKd:  6nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631528(US20230348424, Example 111 | US20230348424, Exampl...)
Affinity DataKd:  6nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
SchröDinger

US Patent
LigandPNGBDBM631530(US20230348424, Example 113 | US20230348424, Exampl...)
Affinity DataKd:  6nMAssay Description:Binding to SOS1 was measured using a SPR assay with purified recombinant human SOS1 substrate (res. 564-1049 with N-terminal Avi tag; purified and bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

Displayed 1 to 50 (of 428 total ) | Next | Last >>
Jump to: